Science Current Events | Science News | Brightsurf.com
 

Cell skeleton may hold key to overcoming drug resistance in cancer

October 04, 2007

Researchers have uncovered a new way in which a cell protein protects cancer cells from a wide range of chemotherapeutic drugs, identifying a possible target for improving treatment outcomes for patients.

A team of scientists at Children's Cancer Institute Australia for Medical Research (CCIA), led by Associate Professor Maria Kavallaris, discovered that the bIII-tubulin component of the cell's cytoskeleton could play an important role in resistance to a wide range of drugs used to treat lung, ovarian and breast cancers.

Advanced non-small cell lung carcinomas (NSCLC) account for more than 80 per cent of lung cancer cases. More than one million people are diagnosed with lung cancer every year, the most common cancer in the world and the leading cause of cancer deaths. Chemotherapy remains the most effective treatment option, involving a diverse range of drugs, often used in combination. However, the emergence of drug-resistant tumours in NSCLC means chemotherapy no longer holds the promise of a good outcome for many patients.

Increased expression of bIII-tubulin has been linked to drug resistance in NSCLC, ovarian and breast cancers. In the latest Cancer Research publication, Associate Professor Kavallaris and her team showed that blocking the expression of the bIII-tubulin gene in NSCLC cells led to an increase in their sensitivity to a range of chemotherapeutic drugs.

"Our results strongly suggest that the bIII-tubulin component is responsible for protecting NSCLC cells from the action of key chemotherapeutic drugs," said Associate Professor Kavallaris.

"This is the first scientific evidence for the broader implications of abnormal expression of this protein.

"We now have new insight into a mechanism of drug resistance in NSCLC which has not previously been reported. This has important implications for improving the targeting and treatment of a number of cancers which are resistant to current chemotherapeutic drugs," said Associate Professor Kavallaris.

Research Australia


Related Chemotherapeutic Drug Current Events and Chemotherapeutic Drug News Articles


Scientists pioneer 3-D-printed drug delivering micro-needles
Researchers have developed a new technique to produce a 3D 'micro-printed' array of needles capable of drug delivery.

Innovative light therapy reaches deep tumors
Light long has been used to treat cancer. But phototherapy is only effective where light easily can reach, limiting its use to cancers of the skin and in areas accessible with an endoscope, such as the gastrointestinal tract.

CNIO associates rare gene variants with side effects from chemotherapy with paclitaxel
Paclitaxel is a chemotherapeutic drug that has been shown to be highly effective when treating solid tumours, such as breast, ovarian and lung tumours.

Major discovery on the mechanism of drug resistance in leukemia and other cancers
A mechanism that enables the development of resistance to Acute Myeloid Leukemia (AML) anticancer drugs, thereby leading to relapse, has been identified by Kathy Borden of the University of Montreal's Institute for Research in Immunology and Cancer (IRIC) and her collaborators.

Genetic aberration paves the way for new treatment of cancer disease
Researchers from Faculty of Health and Medical Sciences, University of Copenhagen, have characterized a genetic aberration on a group of colorectal cancer patients.

Nanotech system, cellular heating may improve treatment of ovarian cancer
The combination of heat, chemotherapeutic drugs and an innovative delivery system based on nanotechnology may significantly improve the treatment of ovarian cancer while reducing side effects from toxic drugs, researchers at Oregon State University report in a new study.

Celery, artichokes contain flavonoids that kill human pancreatic cancer cells
Celery, artichokes, and herbs, especially Mexican oregano, all contain apigenin and luteolin, flavonoids that kill human pancreatic cancer cells in the lab by inhibiting an important enzyme, according to two new University of Illinois studies.

More Effective Immunotherapy for Melanoma Hinges on Blocking Suppressive Factors, Moffitt Cancer Center Researchers Say
Researchers at the Moffitt Cancer Center have found that delayed tumor growth and enhanced survival of mice bearing melanoma were possible by blocking the reconstitution of myeloid-derived suppressor cells and Tregs (suppressors of anti-tumor activity) after total body irradiation had eliminated them.

CWRU School of Medicine researchers discover gene that permanently stops cancer cell proliferation
Researchers at Case Western Reserve University School of Medicine have discovered a mutant form of the gene, Chk1, that when expressed in cancer cells, permanently stopped their proliferation and caused cell death without the addition of any chemotherapeutic drugs.

Regulation by proteins outside cancer cells points to potential new drug target
Protein interactions outside breast cancer cells can send signals to the cancer cells to permanently stop proliferating, a new study showed in the School of Medicine at The University of Texas Health Science Center San Antonio.
More Chemotherapeutic Drug Current Events and Chemotherapeutic Drug News Articles

Basic Principles of Drug Discovery and Development

Basic Principles of Drug Discovery and Development
by Benjamin Blass (Author)


Basic Principles of Drug Discovery and Development presents the multifaceted process of identifying a new drug in the modern era, providing comprehensive explanations of enabling technologies such as high throughput screening, structure based drug design, molecular modeling, pharmaceutical profiling, and translational medicine, all areas that have become critical steps in the successful development of marketable therapeutics. The text introduces the fundamental principles of drug discovery and development, also discussing important drug targets by class, in vitro screening methods, medicinal chemistry strategies in drug design, principles in pharmacokinetics and pharmacodynamics, animal models of disease states, clinical trial basics, and selected business aspects of the drug discovery...

Physicians' Cancer Chemotherapy Drug Manual 2015

Physicians' Cancer Chemotherapy Drug Manual 2015
by Edward Chu (Author), Vincent T. DeVita Jr. (Author)


Completely revised and updated for 2015, the Physicians’ Cancer Chemotherapy Drug Manual is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalogue of over 100 drugs and commonly used drug regimens―both on- and off-label―for the treatment of all the major cancers. SPECIAL FEATURES: • Revised to reflect rapid advances in the field, incorporating treatment strategies and new drugs like afatinib, ceritinib, ibrutinib, idelalisib, obinutuzumab, and ramucirumab. • A specific chapter focused on profiling antiemetic drugs and antiemetic treatment regimens. • Diagrams of drug structures and pathways for many of...

Basic and Clinical Pharmacology 13 E

Basic and Clinical Pharmacology 13 E
by Bertram Katzung (Author), Anthony Trevor (Author)


Gain a full understanding of the basic science andclinical use of drugs with the most up-to-date andcomprehensive pharmacology text in the health sciences400 ILLUSTRATIONS--MANY IN FULL COLORA Doody's Core Title for 2015!Coverage that spans every aspect of medical pharmacology: Encompasses every aspect of medical pharmacology including botanicals and over-the-counter drugs New chapter on pharmacogenomics with important examples Emphasis is placed on discussion of druggroups and prototypes Clinically relevant, the book includes sections that specifically address the clinical choice and use of drugs in patients and the monitoring of their effects Full-color presentation with more than 400 illustrations Case studies introduce clinical problems in most chapters Summary tables and diagrams...

MedNotes: Pocket Drug Guide (Davis's Notes)

MedNotes: Pocket Drug Guide (Davis's Notes)
by Judith Hopfer Deglin PharmD (Author), April Hazard Vallerand PhD RN FAAN (Author)


A DAVIS’S NOTES BOOK! Instant access to all of the essential medical information you need! Drawing on the content of its best-selling parent reference, Davis’s Drug Guide for Nurses, it provides essential information on over 170 top medications commonly prescribed in acute and ambulatory care, including high-alert and emergency drugs! Quickly find content on patient safety—with vital information on pediatric and geriatric considerations—as well as precautions for all vulnerable populations.

Litt's Drug Eruption and Reaction Manual, 21st Edition

Litt's Drug Eruption and Reaction Manual, 21st Edition
by Jerome Z. Litt (Author)


Internationally relied upon by medical practitioners for its unparalleled focus on adverse effects and cutaneous reactions, Litt’s Drug Eruption & Reaction Manual is a succinct clinical reference and essential drug-safety tool for patient care. The new edition has been comprehensively revised and updated, featuring an enlarged section of tables for class reactions and new entries for recently licensed drugs. It has been comprehensively revised and updated throughout to act as a quick reference, and each entry includes: Summaries of numbers of reports and incidence for reactions Clinically important and potentially hazardous drug–drug interactions Categories of adverse drug reactions, eruptions, and cutaneous reaction patterns Essential reference information on prescription and...

Litt's D.E.R.M. Drug Eruptions and Reactions Manual, 20th Edition (Drug Eruption Reference Manual)

Litt's D.E.R.M. Drug Eruptions and Reactions Manual, 20th Edition (Drug Eruption Reference Manual)
by Jerome Z. Litt (Author)


Relied upon by dermatologists and medical practitioners internationally for its unparalleled practical focus on adverse effects and cutaneous reactions, this text is the essential quick-reference tool for patient care and drug safety. The reaction data for this new 20th edition is compiled from the companion website, which is updated continuously, and includes prescription and over-the-counter drugs as well as biologics, supplements, and other medical products―with tens of thousands of adverse drug reactions, eruptions, and reaction patterns. The text notes the number of peer-reviewed references for reaction listings, the reported incidence of a reaction, and clinically important and potentially serious interactions between drugs.

Drug Metabolism and Transport: Molecular Methods and Mechanisms (Methods in Pharmacology and Toxicology)

Drug Metabolism and Transport: Molecular Methods and Mechanisms (Methods in Pharmacology and Toxicology)
by Lawrence H. Lash (Editor)


A compendium of proven experimental approaches and strategies for studying the bioactivation, detoxification, tissue distribution, and elimination of xenobiotics in the metabolism and/or transport of various chemicals. The authors address several of the major drug metabolizing systems, including the cytochrome P450 family, flavin-containing monooxygenases, glutathione, S-transferase, glucuronidation, N-acetylation, and sulfotransferases. Additional chapters present novel approaches to the study of: signaling pathways in the regulation of drug metabolism enzymes, how the modulation of thiols and other low molecular-weight cofactors can alter drug metabolism, and how modulation of drug metabolism pathways can influence antiviral therapy.

Psychopharmacology: Drugs, the Brain and Behavior

Psychopharmacology: Drugs, the Brain and Behavior
by Jerrold S. Meyer (Author), Linda F. Quenzer (Author)


Recent advances in molecular pharmacology and brain imaging have revolutionized our understanding of how psychoactive drugs work. Now, from the authors of Principles of Neuropsychopharmacology, comes a new undergraduate textbook integrating these developments. The first section of the book provides extensive foundation materials, including the basic principles of pharmacology, neurophysiology and neuroanatomy, synaptic transmission, and methods in psychopharmacology. The second section describes key features of major neurotransmitter systems, including the catecholamines, serotonin, acetylcholine, glutamate and GABA. The third and fourth sections discuss theories and mechanisms of drug addiction and psychopathology. All major substances of abuse as well as drugs used to treat mental...

Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy (Cancer Drug Discovery and Development)

Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy (Cancer Drug Discovery and Development)
by Benjamin Bonavida (Editor)


This book reviews novel approaches developed to reverse tumor cell resistance to chemo/immuno/radio-therapy and the use of various sensitizing agents in combination with various cytotoxics. It also introduces several current approaches developed by established investigators that are aimed at overcoming resistance. This is the first volume to compile studies on tumor cell sensitization. It will prove useful for students, scientists, clinicians and pharmaceutical companies.

Prioritization, Delegation, and Assignment: Practice Exercises for the NCLEX Examination, 3e

Prioritization, Delegation, and Assignment: Practice Exercises for the NCLEX Examination, 3e
by Linda A. LaCharity PhD RN (Author), Candice K. Kumagai RN MSN (Author), Barbara Bartz RN MN CCRN (Author)


"..certainly a great resource for use in any healthcare setting." Reviewed by Anne Duell on behalf of Nursing Times, September 2015UNIQUE! Emphasis on the NCLEX Examination’s management-of-care focus addresses the heavy emphasis on prioritization, delegation, and patient assignment in the current NCLEX Examination (17-23% of the 2013 NCLEX-RN Exam).UNIQUE! Three-part organization establishes foundational knowledge and then provides exercises of increasing difficulty to help you build confidence in your prioritization, delegation, and patient assignment skills.Answer key at the back of the book offers a detailed rationale and an indication of the focus of the question to encourage formative assessment.Introduction chapter by delegation expert Ruth Hansten provides guidelines for...

© 2016 BrightSurf.com